TTK Healthcare Limited , a diversified consumer goods and healthcare company, has reported mixed financial results for the first quarter. The company saw an increase in revenue but experienced a significant drop in profitability compared to the same period last year.

Revenue Growth

TTK Healthcare's revenue from operations rose to ₹2,264.30 crore, up from ₹2,079.02 crore in the corresponding quarter of the previous year. This represents a year-on-year growth of approximately 8.91%, indicating a positive trend in the company's top-line performance.

Profit and EBITDA Decline

Despite the revenue growth, the company's net profit saw a substantial decrease. TTK Healthcare reported a net profit of ₹130.00 crore for the quarter, compared to ₹315.70 crore in the same period last year, marking a significant decline of about 58.82%.

Furthermore, TTK Healthcare's Q1 EBITDA dropped significantly to ₹27.00 crore compared to ₹69.00 crore in the same period last year, representing a 60.87% year-over-year decline. The company's EBITDA margin also compressed to 1.19% from 3.32% in the previous year's corresponding quarter, indicating reduced profitability.

Segment Performance

The company's financial results reveal varied performances across its different business segments:

The Consumer Products segment emerged as the largest revenue contributor, while the Protective Devices segment showed the highest profitability.

Financial Position

As of the reporting date, TTK Healthcare's total assets stood at ₹13,108.66 crore, with total liabilities of ₹2,322.46 crore. The company maintained a strong equity position with a paid-up equity share capital of ₹141.30 crore.

Management Commentary

The company's board of directors reviewed and approved these financial results at a meeting held on August 4. The meeting, which began at 12:00 noon and concluded at 12:50 p.m., was conducted with provisions for video conferencing.

TTK Healthcare's performance this quarter reflects the challenges faced by many companies in the current economic environment. While the company has managed to grow its revenue, the significant drop in profitability and EBITDA may be a cause for concern for investors and stakeholders.

The company continues to operate across diverse segments, from animal welfare products to consumer goods and medical devices. This diversification strategy may help TTK Healthcare navigate through sector-specific challenges and capitalize on growth opportunities in different markets.

TTK Healthcare Limited , a diversified healthcare company, recently held its 67th Annual General Meeting (AGM) via video conferencing, revealing a mixed financial performance for the fiscal year. The company reported a 6% increase in revenue and maintained its dividend payout despite facing challenges in some business segments.

Financial Highlights

TTK Healthcare's revenue from operations grew to Rs 801.49 crores, up from Rs 752.79 crores in the previous year, marking a 6% increase. The company's pre-tax profit saw a significant jump to Rs 108.33 crores, compared to Rs 84.12 crores in the previous year. However, it's important to note that this figure includes one-time income of Rs 19.77 crores from the sale of leasehold land and a Rs 5.86 crores write-off of male contraceptive inventories.

The company's earnings per share (EPS) improved to Rs 57.79, up from Rs 44.47 in the previous year. TTK Healthcare maintains a strong financial position with a cash balance of approximately Rs 900 crores as of March 31.

Business Segment Performance

TTK Healthcare's performance varied across its diverse business segments:

1. Consumer Products Division (CPD): Reported static performance, with challenges in the Woodward's Gripe Water segment.
2. EVA: Achieved 5% growth, benefiting from successful marketing campaigns.
3. Skore: Reported 12% volume growth, despite value decline in traditional trade.
4. Good Home: Sustained 15% growth, with new product launches performing well.
5. Animal Welfare Division: Grew by 9%, with varying performance across sub-segments.
6. Medical Devices:
   • Heart Valve Division: Reported 3% value growth.
   • Ortho Division: Achieved 18% revenue growth.
7. Protective Devices: Grew by 9%, despite challenges with USAID orders.
8. Foods Business: Reported 8% revenue growth, with focus on exports and new product development.

Dividend and Future Outlook

The board of directors recommended maintaining the dividend at Rs 10 per share (100%), the same as the previous year. Looking ahead, the company expressed a positive outlook, citing various strategic initiatives across its business segments.

AGM Proceedings

During the AGM, shareholders adopted the audited financial statements, declared the dividend, reappointed directors, and appointed auditors through e-voting. The meeting also addressed various queries from registered speakers regarding the company's performance and operations.

TTK Healthcare's management highlighted plans for each business segment, focusing on brand strengthening, product innovation, market expansion, and operational efficiencies to drive growth in the coming year.

As TTK Healthcare navigates a complex market environment, the company's diversified portfolio and strategic initiatives aim to sustain growth and profitability across its various business segments in the future.